UBS Maintains a 'Buy' on Mylan (MYL); Don't Underestimate the EpiPen

July 31, 2012 2:05 PM EDT Send to a Friend
UBS maintains a 'Buy' on Mylan (NASDAQ: MYL) price target of $28.00.

Analyst, Marc Goodman, reminds investors not to underestimate the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login